«It would be great to see this in
other tumor models.»
Not exact matches
In the Cell study, Dr. Massagué, with Fellow Manuel Valiente, PhD, and
other team members, found that in mouse
models of breast and lung cancer — two
tumor types that often spread to the brain — many cancer cells that enter the brain are killed by astrocytes.
The stem cell
model says that
tumor growth is more hierarchical, mainly driven by a subset of cells that can make new copies of themselves and give rise to the
other cell types the
tumor contains.
«In the future, our
models should provide robust tools to screen for therapies that impact
tumor dormancy and metastasis, and should also provide a platform to solve
other biological mysteries that underlie dormancy.»
In experiments with cancer cell lines, the PIM1 inhibitors killed cells in a MYC - dependent manner, and in two different mouse
models — one in which mice were implanted with patient
tumors and the
other in which a genetic alteration of MYC predisposes the mice to
tumor development — the administration of PIM1 inhibitors resulted in significant
tumor regression.
Their recent study, which appears as the cover article in the May issue of Cancer Research, shows that mathematical
models can be used to predict how different
tumor cell populations interact with each
other and respond to a changing environment.
The next stage of research conducted by Prins and Liau will verify these findings in
other brain
tumor models.
In mouse
models of cancer, targeted therapeutic inhibition of translation disrupts this survival response, dramatically slowing
tumor growth and potentially rendering drug - resistant
tumors vulnerable to
other therapies.
Our PDX
models and
other next - generation cancer
modeling platforms allow you to address critical questions in oncology research, such as unexplained drug resistance, drug efficacy, genomic heterogeneity in solid
tumor, and the role of the immune system in drug response.
Other animal
models either express oncogenes in a tissue - specific manner or shut down the expression of
tumor suppressor genes in the whole tissue.
Other applications the lab is investigating include modeling tumors that metastasize to other parts of the
Other applications the lab is investigating include
modeling tumors that metastasize to
other parts of the
other parts of the body.
Finally, I have a category of «
other cancers» with exomes published in 2011; these include pancreastic cysts and cell lines, gastric cancer
tumors, and prostate cancer samples derived through mouse xenograft
models.
Although this possibility has not yet attracted as much attention as the ideas of cell replacement, personalized medicine and
other more direct clinical applications, hESCs are expected to be superior to most commonly used cell - culture
models of drug discovery which employ
tumor - derived or immortalized cell lines or primary cell culture.
After discussing similar effects in
other animal
models of cancer and a few studies showing the ability of antioxidants to prevent cancer growth, Campbell concluded that «a pattern was beginning to emerge: nutrients from animal foods increased
tumor development while nutrients from plant - based foods decreased
tumor development.»
In the mouse
models, it was also able to stop
tumors from growing and it helped
other forms of chemotherapy to work more effectively.